Second and third hepatectomies for recurrent hepatocellular carcinoma are justified

医学 肝切除术 肝细胞癌 外科 治疗 胃肠病学 内科学 切除术 疾病
作者
Chih‐Ching Wu,S-B Cheng,D-C Yeh,Jiaan‐Der Wang,F-K P'eng
出处
期刊:British Journal of Surgery 卷期号:96 (9): 1049-1057 被引量:79
标识
DOI:10.1002/bjs.6690
摘要

Abstract Background Liver resection is the main curative treatment for hepatocellular carcinoma (HCC), but recurrence rates are high. The remnant liver is the most common site of recurrence, but the role of repeat hepatectomy in the treatment of recurrent HCC is controversial. Methods Patients who underwent curative hepatectomy for HCC and subsequent repeat hepatectomy for recurrent HCC between 1990 and 2007 were reviewed retrospectively. Clinicopathological characteristics, and early- and long-term outcomes of patients who had a first, second, third and fourth hepatectomy were compared. Results Some 1177 patients underwent a first hepatectomy for HCC, and 149, 35 and eight patients respectively had a second, third and fourth hepatectomies for recurrence. There were no significant differences in early postoperative outcomes after first and repeat hepatectomies. Five-year disease-free and overall survival rates after first, second and third hepatectomies were 43·6, 31·8 and 33·8 per cent (P = 0·772), and 52·4, 56·4 and 59·4 per cent (P = 0·879), respectively. Patients undergoing second and third hepatectomies for recurrence had better survival rates than those who did not have a repeat hepatectomy, but not those after fourth hepatectomy. Conclusion Second and third hepatectomies seem justified for hepatic recurrence of HCC. The role of fourth hepatectomy needs further investigation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
竹筏过海应助asd采纳,获得30
1秒前
1秒前
若兰完成签到,获得积分20
1秒前
赘婿应助听雪采纳,获得10
2秒前
2秒前
3秒前
科研达人发布了新的文献求助10
6秒前
廖尔阳完成签到,获得积分10
6秒前
红黄蓝完成签到 ,获得积分10
7秒前
7秒前
芝曳汁发布了新的文献求助10
7秒前
Natasha发布了新的文献求助10
8秒前
完美世界应助廖尔阳采纳,获得10
10秒前
鱿鱼完成签到,获得积分10
11秒前
北斗HH完成签到,获得积分10
12秒前
Jasper应助鬼才之眼采纳,获得10
12秒前
DARKNESS完成签到,获得积分10
13秒前
神勇香萱关注了科研通微信公众号
13秒前
Orange应助谢朝邦采纳,获得10
14秒前
乔力番阿衣完成签到,获得积分10
15秒前
落后冬云完成签到 ,获得积分10
16秒前
16秒前
桐桐应助科研通管家采纳,获得10
18秒前
JamesPei应助科研通管家采纳,获得10
18秒前
ding应助科研通管家采纳,获得10
18秒前
思源应助科研通管家采纳,获得10
18秒前
研友_Y59785应助科研通管家采纳,获得10
18秒前
猪猪hero应助科研通管家采纳,获得10
19秒前
19秒前
桐桐应助科研通管家采纳,获得10
19秒前
19秒前
Orange应助科研通管家采纳,获得10
19秒前
小二郎应助科研通管家采纳,获得10
19秒前
若渝12345完成签到,获得积分10
23秒前
23秒前
广州小肥羊发布了新的文献求助100
23秒前
Akim应助安娜采纳,获得10
24秒前
25秒前
26秒前
小杨完成签到,获得积分20
26秒前
高分求助中
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
지식생태학: 생태학, 죽은 지식을 깨우다 600
Mantodea of the World: Species Catalog Andrew M 500
海南省蛇咬伤流行病学特征与预后影响因素分析 500
Neuromuscular and Electrodiagnostic Medicine Board Review 500
ランス多機能化技術による溶鋼脱ガス処理の高効率化の研究 500
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3464175
求助须知:如何正确求助?哪些是违规求助? 3057476
关于积分的说明 9057425
捐赠科研通 2747569
什么是DOI,文献DOI怎么找? 1507398
科研通“疑难数据库(出版商)”最低求助积分说明 696533
邀请新用户注册赠送积分活动 696062